Clinical Trial Update: Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating stem cell infusion for neurological sequelae after ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Stem cell infusion therapy

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED